This program aims to establish Centers for Accelerating Phage Therapy to combat ESKAPE pathogens. These Centers will develop preclinical assays, tools, and models and conduct essential studies that facilitate robust phage therapeutics against ESKAPE pathogens, contributing significantly to the fight against antibiotic resistance.
Amount: $9,060,000
Due Date: 12/27/2024 (LOI); 01/28/2025 (Full Proposal)